Vera Therapeutics, Inc. (VERA) NASDAQ

48.41

-0.69(-1.41%)

Updated at January 14 04:00PM

Currency In USD

Valuation

Market Cap2.34B
Enterprise Value2.3B
P/E Ratio-14.15
PEG Ratio0.76
Price/Sales Ratio0
Price/Book Ratio6.59
Enterprise/Revenue0
Enterprise/EBITDA-14.36

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.38
Return On Equity-0.47

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-144.42M
Net Income-152.15M
Diluted EPS-2.75

Balance Sheet

Total Cash497.39M
Total Cash/Share8.73
Total Debt77.22M
Total Debt/Equity0.17
Current Ratio16.92
Book Value Per Share7.34

Price History

52-Week Change42.89
52-Week High56.05
52-Week Low18.53
Moving Average 50 Days40.28
Moving Average 200 Days28.01

Statistics

Average Volume1.55M
Shares Outstanding63.93M
% Held by Institutions102

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A